What Can the Pharma Industry Learn from Merck’s New Antiviral?

 

Merck is one of the first pharmaceutical companies to submit an antiviral candidate to the FDA for approval, signaling the beginning of a new phase of mass production of COVID treatment drugs. For Merck’s oral antiviral, molnupiravir, its optimistic success can be largely credited to its federal funding. Work on the related compound was active at Emory University as far back as 2004, with millions

With that kind of federal investment, and Operation Warp Speed validating the role of the federal government in supporting critical biomedical development, we wanted to know: can the industry expect any further involvement, financial or regulatory, from the federal government around COVID treatments? Plus, as Operation Warp Speed accelerated the COVID vaccine research timeline, are there more sustainable ways to bring this level of turnaround to other parts of the pharmaceutical pipeline without lags in treatment quality or oversight?

MarketScale sourced Dr. Kishor M. Wasan, Chief Medical and Scientific Officer at Skymount Medical, for his perspective, pulling from his active research around drug production and AI. Scroll down for his various insights!

1. Do the Successes of Operation Warp Speed Validate the Support of the Federal Government?

 

2. How LSU Designed a Model to Speed Up the Evaluation of Drug Candidates

 

3. How the Pharmaceutical Pipeline can Balance Speed and Quality

 

Follow us on social media for the latest updates in B2B!

Image

Latest

Exceptional Customer Service in Healthcare is the Cornerstone of Building Patient Trust
November 12, 2024

The significance of excellent customer service in every corner and industry cannot be overstated. This notion is especially crucial in healthcare, where patient experiences often influence their recovery and overall well-being. The topic of customer service in the medical field is always a priority in healthcare because providers strive to enhance patient satisfaction and…

Read More
eVTOL certification
Safran’s AI, Telemetry, and Data Precision Pave the Way for eVTOL Certification
November 11, 2024

The electric vertical takeoff and landing (eVTOL) industry is set to transform urban transportation by addressing congestion and promoting sustainable travel options. Experts predict the global eVTOL market will surge to $39 billion by 2033, with a compound annual growth rate (CAGR) of 36.8% over the next decade. This rapid expansion is fueled by…

Read More
A Plan for the Future: A Legacy of Love, Giving from a Grand Dad with Ken Bissell
November 11, 2024

Everyone knows that parenting is not an easy feat, but raising twins takes parenting to another level. Such a journey is one that Ken Bissell had with his wife and now stands to showcase the power of partnership, patience, and resilience in family life. Including his twins, Bissell is a father to a total…

Read More
Fighting for Fair Healthcare Access Means Overcoming Certain Challenges
November 8, 2024

With healthcare costs continuing to climb, and the access to quality care remaining uneven, discussions on healthcare reform are quite an essential topic. Millions of Americans face high out-of-pocket costs and limited access to critical health services. According to a 2022 Gallup poll, nearly 40 percent of Americans have delayed medical care due to…

Read More